GADOBUTROL vs GADODIAMIDE

Compare GADOBUTROL (Gadobutrol) and GADODIAMIDE (OMNISCAN) — clinical data, side effects, and patient experiences.

GADOBUTROL

Gadobutrol · Diagnostic Agent

How it works

12.1 Mechanism of Action In MRI, visualization of normal and pathological tissue depends in part on variations in the radiofrequency signal intensity that occurs with: • Difference...

Approved for

including term neonates ( 1.3 ) • To assess myocardial perfusion (stress

including term neonates

to evaluate known or suspected supra-aortic or renal artery disease. 1.4 Cardiac MRI Gadobutrol injection is indicated for use in cardiac MRI (CMRI) to assess myocardial perfusion (stress

rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

IntravenousTablet

GADODIAMIDE

OMNISCAN · Diagnostic Agent

How it works

12.2 Pharmacodynamics In magnetic resonance imaging, visualization of normal and pathologic tissue depends in part on variations in the radiofrequency signal intensity. These varia...

Approved for

spine

and associated tissues ( 1.1 ) Facilitate the visualization of lesions with abnormal vascularity within the thoracic

abdominal

pelvic cavities

IntravenousTablet

Quick Comparison

GADOBUTROLGADODIAMIDE

Drug Class

Diagnostic Agent

Route

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

GADOBUTROL

Nausea

>10%

Vomiting

>10%

Itching

>10%

Shortness of Breath

1-10%

Dizziness

0.1-1%

Rash

0.1-1%

Cough

0.1-1%

Headache

0.1-1%

GADODIAMIDE

Anxiety

1-10%

Joint Pain

0.1-1%

Peripheral Edema

0.1-1%

Rash

0.1-1%

Weakness

0.1-1%

FDA Warnings

GADOBUTROL

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Anaphylactic and other hypersensitivity reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have occurred
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

GADODIAMIDE

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Anaphylactoid and other serious hypersensitivity reactions including fatal reactions have occurred particularly in patients with history of allergy or drug reactions
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

Clinical Trial Data

No head-to-head clinical studies found for GADOBUTROL vs GADODIAMIDE.

GADOBUTROL vs GADODIAMIDE: What You Should Know

Key Differences

Both GADOBUTROL and GADODIAMIDE belong to the Diagnostic Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

GADOBUTROL carries 4 FDA warnings. GADODIAMIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

AIR 90% CARBON DIOXIDE 10% vs GADOBUTROL→GADOBUTROL vs IOPAMIDOL→CARBON DIOXIDE vs GADOBUTROL→GADOBUTROL vs IODIXANOL→GADOBUTROL vs IOHEXOL→CARBON DIOXIDE-OXYGEN-NITROGEN MIXTURE vs GADOBUTROL→

Loading comparison data...

GADOBUTROL vs GADODIAMIDE

Compare GADOBUTROL (Gadobutrol) and GADODIAMIDE (OMNISCAN) — clinical data, side effects, and patient experiences.

GADOBUTROL

Gadobutrol · Diagnostic Agent

How it works

12.1 Mechanism of Action In MRI, visualization of normal and pathological tissue depends in part on variations in the radiofrequency signal intensity that occurs with: • Difference...

Approved for

including term neonates ( 1.3 ) • To assess myocardial perfusion (stress

including term neonates

to evaluate known or suspected supra-aortic or renal artery disease. 1.4 Cardiac MRI Gadobutrol injection is indicated for use in cardiac MRI (CMRI) to assess myocardial perfusion (stress

rest) and late gadolinium enhancement in adult patients with known or suspected coronary artery disease (CAD).

IntravenousTablet

GADODIAMIDE

OMNISCAN · Diagnostic Agent

How it works

12.2 Pharmacodynamics In magnetic resonance imaging, visualization of normal and pathologic tissue depends in part on variations in the radiofrequency signal intensity. These varia...

Approved for

spine

and associated tissues ( 1.1 ) Facilitate the visualization of lesions with abnormal vascularity within the thoracic

abdominal

pelvic cavities

IntravenousTablet

Quick Comparison

GADOBUTROLGADODIAMIDE

Drug Class

Diagnostic Agent

Route

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

GADOBUTROL

Nausea

>10%

Vomiting

>10%

Itching

>10%

Shortness of Breath

1-10%

Dizziness

0.1-1%

Rash

0.1-1%

Cough

0.1-1%

Headache

0.1-1%

GADODIAMIDE

Anxiety

1-10%

Joint Pain

0.1-1%

Peripheral Edema

0.1-1%

Rash

0.1-1%

Weakness

0.1-1%

FDA Warnings

GADOBUTROL

5 WARNINGS AND PRECAUTIONS • Hypersensitivity Reactions: Anaphylactic and other hypersensitivity reactions with cardiovascular, respiratory or cutaneous manifestations, ranging from mild to severe, including death, have occurred
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

GADODIAMIDE

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Anaphylactoid and other serious hypersensitivity reactions including fatal reactions have occurred particularly in patients with history of allergy or drug reactions
1 Risk Associated with Intrathecal Use Intrathecal administration of GBCAs can cause serious adverse reactions including death, coma, encephalopathy, and seizures
2 Nephrogenic Systemic Fibrosis GBCAs increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs
The GBCA-associated NSF risk appears highest for patients with chronic, severe kidney disease (GFR 60 years, diabetes mellitus or chronic hypertension), estimate the GFR through laboratory testing

Clinical Trial Data

No head-to-head clinical studies found for GADOBUTROL vs GADODIAMIDE.

GADOBUTROL vs GADODIAMIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.